Biohaven wraps patient enrollment for ALS clinical trial arm November 15, 2021 Auto Bot Clinical Development 0 The pharma company has completed enrollment of amyotrophic lateral sclerosis patients in its study investigating drugs like verdiperstat, an oral treatment.